Resmed CDI (ASX:RMD)
Health Care Equipment & Services
share price: (EoD)
earnings per share:
dividends per share:
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) share price news
Today's ASX news
ASX 200 set to fall – APT, Z1P & WOW shares in focus
The S&P/ASX 200 (ASX: XJO) finished 0.1% higher on Friday as markets continued to digest the week’s change of heart from the Federal Reserve.
June 21, 2021
ASX Growth Shares
Eyes on the ResMed (ASX:RMD) share price
The ResMed CDI (ASX: RMD) share price is in the spotlight as it released its Q3 update. How will this update affect the ResMed share price?
April 30, 2021
ASX Growth Shares
2 ASX tech shares to buy for the next decade
There are some quality ASX tech shares that Aussies can buy for their portfolios. I believe they could be buys today for the next decade.
March 11, 2021
ASX Growth Shares
Q2: Here’s why the ResMed (ASX:RMD) share price is on watch
The ResMed Inc (ASX:RMD) share price is on watch this morning after announcing growth in its FY21 second quarter.
January 29, 2021
ASX Share Ideas
Best ETFs 2021: 3 ethical ETFs to watch
Here are 3 of my top ethical ETFs for Australian investors in 2021. BetaShares Global Sustainability Leaders ETF (ASX: ETHI), eInvest Future Impact Small Caps Fund (ASX: IMPQ) and Vanguard Ethically Conscious International Shares Index ETF (ASX: VESG).
December 12, 2020
ASX Growth Shares
Why I think the ResMed (ASX:RMD) share price is a buy
ResMed CDI (ASX:RMD) shares have a long history of outperformance and delivering impressive returns for its shareholders. Is it too late to buy ResMed shares?
November 9, 2020
Reporting Season 2024
S&P/ASX 200 morning report – AMP, RMD & US big tech shares in focus
The S&P/ASX 200 (ASX: XJO) is expected to trade higher on Monday morning, according to data from the Sydney Futures Exchange. ResMed Inc (ASX:RMD) and AMP Ltd (ASX:AMP) shares are in focus.
November 2, 2020
Today's ASX news
S&P/ASX 200 morning report – MYR, NCK & RMD shares in focus
The S&P/ASX 200 (INDEXASX: XJO) is expected to edge lower when the market opens this morning. Myer (ASX: MYR), Nick Scali (ASX: NCK) and ResMed (ASX: RMD) shares are making headlines.
August 7, 2020
ASX Growth Shares
FY20 result: ResMed (ASX:RMD) profit jumps 40%
The ResMed Inc (ASX:RMD) profit jumped 40% in its FY20 result due to high ventilator demand. The ResMed share price is expected to open lower.
August 6, 2020
